SCHEMBL20026360

SCHEMBL20026360

CO[C@H](c1ccc(N2C[C@@H]3[C@@H](N)[C@@H]3C2)cc1)[C@H](N)CF

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15628607 0.81 ALDH1A1 (0.38) —
SCHEMBL15628549 0.81 DPP4 (0.35) ACACB
SCHEMBL15628606 0.81 DPP4 (0.35) ACACB
SCHEMBL13527732 0.80 — —
SCHEMBL14568427 0.80 — —
SCHEMBL15628457 0.80 ALDH1A1 (0.40) —
SCHEMBL20026384 0.79 — —
SCHEMBL15628617 0.79 WDR91 (0.40) ACACB
SCHEMBL15628618 0.79 WDR91 (0.40) ACACB
SCHEMBL19062581 0.78 ALDH1A1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same BioVersys AG (CH) 2018-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same IL33, PROKR1, VIP ACACB 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback